Events

Zinereo Pharma at Probiota Copenhagen 2025 – Advancing Science and Business in the Microbiome Industry

We have been actively in Probiota Copenhagen 2025, a key event that bridges science and business in the microbiome industry. This gathering has been an incredible opportunity to learn about the latest scientific advances, explore new innovations, and strengthen strategic partnerships.

Throughout the event, we engaged in insightful scientific discussions, deepened our understanding of microbiota applications, and explored new business opportunities with industry leaders. Our participation reaffirmed Zinereo Pharma’s commitment to cutting-edge research and the development of evidence-based probiotic solutions.

Additionally, we were honored to take part in a board meeting of the International Probiotics Association (IPA), contributing to discussions that are shaping the future of the probiotics industry on a global scale.

As a ZENDAL company, we continue our mission to innovate, expand, and collaborate in bringing scientifically backed health solutions to more people worldwide. Exciting times ahead!

Zinereo Pharma has sponsored the 2nd Scientific Meeting of the SPIMP– The Virtuous Circle of the Microbiome, in Lisbon

In January 2025, Zinereo Pharma sponsored the 2nd Scientific Meeting – The Virtuous Circle of the Microbiome in Lisbon. This prestigious event, organized by SPIMP, is a key platform in Portugal for advancing knowledge about the microbiome and the critical role of probiotics in health.

A full day dedicated to scientific advances, featuring insightful lectures, latest researchs in the field and discussions on how the microbiome influences human health and disease management. These kind of events help bridge the gap between research and clinical practice, allowing healthcare professionals to apply the latest findings to patient care.

Beyond the science, this meeting provides an invaluable opportunity for networking, exchanging ideas, and fostering collaborations

Zinereo Pharma Expands Global Presence and Announces Key Partnerships at Arab Health Dubai 2025

Zinereo Pharma took another step forward in its global expansion by participating in Arab Health Dubai 2025, the premier healthcare event in the Middle East. Our presence at this influential gathering was focused on strengthening existing partnerships, exploring new business synergies, and driving innovation in healthcare solutions.

This year, we engaged in high-level discussions with our current partners, reinforcing strategic collaborations and expanding our global network. A key highlight was the announcement of our exclusive distribution agreement with Thabbath for Reutopic in Saudi Arabia, marking a significant milestone in our commitment to delivering cutting-edge dermatological solutions for pets to the region.

Beyond consolidating partnerships, Arab Health provided an invaluable platform to explore new alliances, exchange ideas, and identify licensing opportunities that align with our vision for international growth and innovation.

As we move forward, we remain committed to collaborative innovation and strategic global partnerships, ensuring that our healthcare solutions continue to drive progress in medical science

We had the opportunity to explore the latest innovations in health and wellness ingredients and engage in meaningful discussions.

Our participation was focused on fostering strategic alliances to drive innovation and collaboration in this dynamic sector.

Additionally, we attended an IPA board meeting.

We focused on strengthening our presence in the pharmaceutical sector, particularly by building meaningful business partnerships. This event allowed us connecting key industry players and explore opportunities for international expansion.

Our team engaged in revealing discussions, working towards expanding Zinereo’s global reach and positioning our solutions at the forefront of the pharmaceutical market.

Zinereo strengthened its presence in the Asia-Pacific region at this event, where we focused on promoting women’s health through innovative probiotic solutions.

The event provided a key opportunity to forge strategic partnerships and explore new business synergies, reinforcing our commitment to expanding in this dynamic market.

This event gathered leading experts, researchers, and innovators to explore cutting-edge advancements in probiotics, prebiotics, and microbiome science. It was an incredible opportunity to connect, learn, and contribute to the future of this dynamic field

We also attended an IPA  board meeting

The leading nutraceutical trade fair in Europe offered us an opportunity to showcase our innovative portfolio and explore key trends shaping the future of the nutraceutical, health, and wellness industries.

Our presentation, “Fertibiome: Innovation in Microbiome based Solutions for Infertility”, attracted and engaged significant interest from attendees, allowing us to present our cutting-edge research and advanced probiotic formulation for fertility, forming new partnerships, further driving our mission to expand the benefits of probiotics in healthcare and innovation.

We explored emerging trends in biotechnology and established strategic relationships in the pharmaceutical sector.

Ana Nunes, our Director of Business Development, led key discussions on future challenges and opportunities in biopharma and biomanufacturing, generating valuable connections with experts and innovators driving the advancement of these disciplines. She actively participated in an expert panel discussing the challenges and opportunities of integrating nutraceuticals into healthcare practices.

It was an opportunity to share knowledge and foster collaborations that promote the evolution of the biotech sector.

We actively participated in discussions on the modulation of the human microbiome at all stages of life with the aim of presenting the latest scientific advances in microbiota and their application to clinical practice, at this event.

We also attended the meeting of the Industry Advisory Council.

With the aim of delving deeper into the scientific advances of the microbiome and exploring the latest market trends, we reaffirmed our commitment in this area through our participation in Probiota, an event held in Milan and organized by the International Probiotics Association (IPA), of which we are a member.

Our team actively participated in discussions on microbiome advances and the latest market developments, it was a unique opportunity to collaborate and learn, forming connections and exploring future collaborations to.

We also participated in the IPA Board Meeting.

Zinereo Pharma has made a significant step in expanding into the Middle East through its participation in Arab Health, one of the region’s leading healthcare events.

During the event, the team engaged in strategic meetings with local companies to foster business partnerships that strengthen our presence and support the internationalization of our probiotic portfolio.

The event presented opportunities for internationalization and licensing portfolio agreements and collaborations in a key market for our future.

At the end of May, Zinereo Pharma will be in Madrid to attend Pharmavenue, probably the largest international brand licensing event held in Spain. Our Business Development department will attend this event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.

At the middle of June, Zinereo Pharma will be in Berlin to attend EUROPLX, the largest international brand licensing event held in Europe. Our Business Development department will attend this event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.

Zinereo Pharma will be attending BEPHARMA, the most important B2B networking & partnering event in the pharmaceutical and human healthcare industries in America. Our Business Development department will attend said event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.

At the beginning of September, Zinereo Pharma will be attending Vitafoods Europe. Our Business Development department will attend this event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.

At the middle of October, Zinereo Pharma will be in Frankfurt to attend CPHI. Our Business Development department will attend said event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.

At the beginning of December, Zinereo Pharma will be in Madrid to attend Pharmavenue, probably the largest international brand licensing event held in Spain. Our Business Development department will attend said event to present the portfolio of products and projects available for licensing and distribution in different territories. Contact us to make an appointment.